These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. WT1 splice site mutation in a 46,XX female with minimal-change nephrotic syndrome and Wilms' tumour. Loirat C; André JL; Champigneulle J; Acquaviva C; Chantereau D; Bourquard R; Elion J; Denamur E Nephrol Dial Transplant; 2003 Apr; 18(4):823-5. PubMed ID: 12637656 [No Abstract] [Full Text] [Related]
6. Clinical and molecular characterization of patients with heterozygous mutations in wilms tumor suppressor gene 1. Lehnhardt A; Karnatz C; Ahlenstiel-Grunow T; Benz K; Benz MR; Budde K; Büscher AK; Fehr T; Feldkötter M; Graf N; Höcker B; Jungraithmayr T; Klaus G; Koehler B; Konrad M; Kranz B; Montoya CR; Müller D; Neuhaus TJ; Oh J; Pape L; Pohl M; Royer-Pokora B; Querfeld U; Schneppenheim R; Staude H; Spartà G; Timmermann K; Wilkening F; Wygoda S; Bergmann C; Kemper MJ Clin J Am Soc Nephrol; 2015 May; 10(5):825-31. PubMed ID: 25818337 [TBL] [Abstract][Full Text] [Related]
7. Diagnostic utility of Wilms' tumour-1 protein (WT-1) immunostaining in paediatric renal tumours. Goyal S; Mishra K; Sarkar U; Sharma S; Kumari A Indian J Med Res; 2016 May; 143(Supplement):S59-S67. PubMed ID: 27748279 [TBL] [Abstract][Full Text] [Related]
8. Germline WT1 mutations in Wilms' tumor patients: preliminary results. Li FP; Breslow NE; Morgan JM; Ghahremani M; Miller GA; Grundy PE; Green DM; Diller LR; Pelletier J Med Pediatr Oncol; 1996 Nov; 27(5):404-7. PubMed ID: 8827066 [TBL] [Abstract][Full Text] [Related]
9. Prevalence of WT1 mutations in a large cohort of patients with steroid-resistant and steroid-sensitive nephrotic syndrome. Ruf RG; Schultheiss M; Lichtenberger A; Karle SM; Zalewski I; Mucha B; Everding AS; Neuhaus T; Patzer L; Plank C; Haas JP; Ozaltin F; Imm A; Fuchshuber A; Bakkaloglu A; Hildebrandt F; Kidney Int; 2004 Aug; 66(2):564-70. PubMed ID: 15253707 [TBL] [Abstract][Full Text] [Related]
10. Altered trans-activational properties of a mutated WT1 gene product in a WAGR-associated Wilms' tumor. Park S; Tomlinson G; Nisen P; Haber DA Cancer Res; 1993 Oct; 53(20):4757-60. PubMed ID: 8402654 [TBL] [Abstract][Full Text] [Related]
11. Role of the WT1 gene in Wilms' tumour. Haber DA; Housman DE Cancer Surv; 1992; 12():105-17. PubMed ID: 1322241 [TBL] [Abstract][Full Text] [Related]
12. Genotype/phenotype correlations in Wilms' tumor. Huff V Med Pediatr Oncol; 1996 Nov; 27(5):408-14. PubMed ID: 8827067 [TBL] [Abstract][Full Text] [Related]
13. WT1 mutations may be a cause of severe renal failure due to nephroblastomatosis in Wilms' tumor patients. Santín S; Fraga G; Ruíz P; Pardo N; Torrent M; Martí T; Ballarín J; Ars E; Torra R Clin Nephrol; 2011 Sep; 76(3):244-8. PubMed ID: 21888862 [TBL] [Abstract][Full Text] [Related]
14. Spectrum of early onset nephrotic syndrome associated with WT1 missense mutations. Schumacher V; Schärer K; Wühl E; Altrogge H; Bonzel KE; Guschmann M; Neuhaus TJ; Pollastro RM; Kuwertz-Bröking E; Bulla M; Tondera AM; Mundel P; Helmchen U; Waldherr R; Weirich A; Royer-Pokora B Kidney Int; 1998 Jun; 53(6):1594-600. PubMed ID: 9607189 [TBL] [Abstract][Full Text] [Related]
15. [Four new cases with WT1 gene mutations in Chinese patients with Wilms' tumor]. Jiang YP; Shen Y; Sun N; Wang H Zhonghua Er Ke Za Zhi; 2009 Oct; 47(10):762-6. PubMed ID: 20021811 [TBL] [Abstract][Full Text] [Related]
16. The same mutation affecting the splicing of WT1 gene is present on Frasier syndrome patients with or without Wilms' tumor. Barbosa AS; Hadjiathanasiou CG; Theodoridis C; Papathanasiou A; Tar A; Merksz M; Györvári B; Sultan C; Dumas R; Jaubert F; Niaudet P; Moreira-Filho CA; Cotinot C; Fellous M Hum Mutat; 1999; 13(2):146-53. PubMed ID: 10094551 [TBL] [Abstract][Full Text] [Related]
17. Inactivation of WT1 in nephrogenic rests, genetic precursors to Wilms' tumour. Park S; Bernard A; Bove KE; Sens DA; Hazen-Martin DJ; Garvin AJ; Haber DA Nat Genet; 1993 Dec; 5(4):363-7. PubMed ID: 8298644 [TBL] [Abstract][Full Text] [Related]
18. Dominant negative mutations in the Wilms tumour (WT1) gene cause Denys-Drash syndrome--proof that a tumour-suppressor gene plays a crucial role in normal genitourinary development. Hastie ND Hum Mol Genet; 1992 Aug; 1(5):293-5. PubMed ID: 1338905 [No Abstract] [Full Text] [Related]
19. Extrarenal Wilms' tumors. A study of their relationship with classical renal Wilms' tumor using expression of WT1 as a molecular marker. Roberts DJ; Haber D; Sklar J; Crum CP Lab Invest; 1993 May; 68(5):528-36. PubMed ID: 8388523 [TBL] [Abstract][Full Text] [Related]
20. Early diagnosis of WT1 nephropathy and follow up in a Chinese multicenter cohort. Sun S; Xu L; Bi Y; Wang J; Zhang Z; Tang X; Cao Q; Zhai Y; Chen J; Fang X; Liu J; Fang Y; Xiang T; Qian Y; Wu B; Wang H; Zhou W; Shen J; Dong K; Liu X; Zheng B; Zhang A; Wang X; Wu Y; Ma D; Shen Q; Rao J; Xu H Eur J Med Genet; 2020 Nov; 63(11):104047. PubMed ID: 32891756 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]